ClinicalTrials.Veeva

Menu

Plaque Burden Pre- Myocardial Revascularisation (ByPlaque)

M

Medical University Innsbruck

Status

Completed

Conditions

Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT03774004
1098/2017

Details and patient eligibility

About

The study is a prospective-observational, explorative single-centre cohort study aimed to examine the influence of the peripheral atherosclerotic plaque volume on short and long term morbidity and mortality in patient after coronary artery bypass grafting (CABG).

Atherosclerotic disease (IMT, plaque volume) will be measured with a ultrasound system (IMT measurements and 3D quantitative plaque volumetric). Hemodynamic and flow profiles of the internal thoracic arteries will be evaluated additionally with US. These parameters will be measured pre-CABG.

Morbidity will be evaluated using quality of life questionnaires (EQ-5D-3L, IPAQ). Major adverse cardiovascular events (MACE) will be the primary endpoint. The atherosclerotic burden will be compared with established risk scores (EuroSCORE, STS-Score, SYNTAX Score, FORECAST.

Enrollment

252 patients

Sex

All

Ages

30 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pre CABG

Exclusion criteria

  • no consent, prior carotid intervention

Trial contacts and locations

1

Loading...

Central trial contact

Peter Marschang, MD; Michael Schreinlechner, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems